BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,150,560 | +0.7% | 29,000 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $3,129,970 | -36.1% | 29,000 | -26.2% | 0.01% | -33.3% |
| Q1 2023 | $4,895,601 | -40.2% | 39,300 | -27.9% | 0.01% | -43.8% |
| Q4 2022 | $8,186,990 | +39.2% | 54,500 | +25.0% | 0.02% | +33.3% |
| Q3 2022 | $5,881,000 | -45.2% | 43,600 | -39.4% | 0.01% | +20.0% |
| Q2 2022 | $10,728,000 | -21.3% | 71,949 | -9.9% | 0.01% | 0.0% |
| Q1 2022 | $13,625,000 | -21.1% | 79,882 | +19.2% | 0.01% | -16.7% |
| Q4 2021 | $17,267,000 | -19.1% | 67,002 | -14.3% | 0.01% | -29.4% |
| Q3 2021 | $21,344,000 | +106.7% | 78,188 | +69.6% | 0.02% | +88.9% |
| Q2 2021 | $10,324,000 | +65.7% | 46,112 | -19.2% | 0.01% | +50.0% |
| Q1 2021 | $6,232,000 | +134.4% | 57,075 | +74.9% | 0.01% | +100.0% |
| Q4 2020 | $2,659,000 | -36.5% | 32,625 | -46.0% | 0.00% | -40.0% |
| Q3 2020 | $4,185,000 | +44.7% | 60,447 | +39.5% | 0.01% | +66.7% |
| Q2 2020 | $2,892,000 | – | 43,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |